|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03737 ZHONGZHIPHARM
Nominal 
0.950 -0.020 (-2.062%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 1,088,426 | -0.539% | 1,094,328 | 846,397 | 886,716 | 737,676 |
| Cost of Sales | (461,380) | 10.019% | (419,365) | (341,214) | (340,898) | (279,505) |
| Gross Profit | 627,046 | -7.099% | 674,963 | 505,183 | 545,818 | 458,171 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 105,019 | -37.421% | 167,819 | 95,414 | 80,156 | 91,916 | |
| Taxation | (20,767) | -34.421% | (31,667) | (17,875) | (13,612) | (19,912) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (812) | -35.144% | (1,252) | (491) | 44 | 1 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 83,440 | -38.147% | 134,900 | 77,048 | 66,588 | 72,005 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,735 | 3755.556% | 45 | 1,076 | 1,316 | (1,154) |
| Depreciation & Amortisation | 51,053 | 2.075% | 50,015 | 45,934 | 40,984 | 37,969 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 9.900 | -37.736% | 15.900 | 9.100 | 8.100 | 8.600 |
| DPS (cts) | 0.000 | -- | 5.502 | 0.000 | 0.000 | 4.579 |
| Dividend Payout Ratio (%) | -- | -- | 34.604% | -- | -- | 53.240% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.282 | -- | 1.237 | 1.129 | 1.051 | 0.956 |
| Remarks: | Real time quote last updated: 27/11/2024 10:30 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 83,440 |
| %Change | -38.147% |
| EPS / (LPS) | RMB 0.099 |
| NBV Per Share (¥) | RMB 1.282 |